Folic acid + docosahexaenoic acid
Folic acid + docosahexaenoic acid has been studied in 3 papers since 2020: 2 trials in people, 1 review; 1 in the past year. The newest paper, Feb 28, 2026: “Nutritional supplements and cognition in healthy aging and mild cognitive impairment patients: a systematic review and network meta-analysis”.
See all 12 papers on folic acid + docosahexaenoic acid
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Daily oral FA, DHA and their combined use for 6 months significantly improved the full-scale intelligence quotient (FSIQ)”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Major Research Plan
- Human trial2
Studies in people
2 studies gave folic acid + docosahexaenoic acid to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
| Randomized trial6 months | 160 peopleover the age of 60MCI patients | Journal of Alzheimer's disease reports, Sep 27, 2024 | |
up: Improves full-scale intelligence quotient down: Decreases plasma inflammatory cytokines | Randomized trial6 months | 240 peopleelderlyOlder adults; mild cognitive impairment, compared with placebo | European journal of nutrition, Aug 28, 2020 |
What did studies of folic acid + docosahexaenoic acid find?
3Studies of folic acid + docosahexaenoic acid measured 3 outcomes: amyloid-beta 42, plasma inflammatory cytokines and full-scale intelligence quotient.
Amyloid-beta 42
downin humans1
1 study
Amyloid-beta 42
downin humans1
Folic acid + docosahexaenoic acid decreases amyloid-beta 42 in humans.
“The GEE analysis revealed that over the 6-month intervention, FA supplementation alone, and in combination with DHA led to a significant reduction in Aβ42, Aβ40, and AβPP levels (p < 0.05”
Human trial6 months
Journal of Alzheimer's disease reports
Plasma inflammatory cytokines
downin humans1
1 study
Plasma inflammatory cytokines
downin humans1
Folic acid + docosahexaenoic acid decreases plasma inflammatory cytokines in humans (mild cognitive impairment, compared with placebo).
“Daily oral FA, DHA and their combined use for 6 months significantly decreased plasma inflammatory cytokines compared to the placebo.”
Human trialmild cognitive impairment, compared with placeboFA 800 μg/d + DHA 800 mg/d6 monthsn = 240
European journal of nutrition
Full-scale intelligence quotient
upin humans1
1 study
Full-scale intelligence quotient
upin humans1
Folic acid + docosahexaenoic acid improves full-scale intelligence quotient in humans (mild cognitive impairment, compared with placebo).
“Daily oral FA, DHA and their combined use for 6 months significantly improved the full-scale intelligence quotient (FSIQ)”
Human trialmild cognitive impairment, compared with placeboFA 800 μg/d + DHA 800 mg/d6 monthsn = 240
European journal of nutrition